NCT05035849View on ClinicalTrials.gov

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

May 5, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

sitagliptin and acarbose

One group used first sitagliptin and metformin, then used acarbose and metformin. Another group used first acarbose and metformin, then used sitagliptin andmetformin.

Trial Locations (1)

Unknown

Gu Gao, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT05035849 - Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose | Biotech Hunter | Biotech Hunter